Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Case Reports in Neurology|October 2, 2019
Combined Hypertrophic Pachymeningitis and Cerebral Venous Thrombosis in a Case of Granulomatosis with PolyangiitisTadahiro Kuribayashi, Yasuhiro Manabe, Shunya Fujiwara, et al.
Internal Medicine (Tokyo, Japan)|September 21, 2022
Fulminant Myocarditis for Non-small-cell Carcinoma of the Lung with Nivolumab and Ipilimumab Plus ChemotherapyTomoka Nishimura, Kiichiro Ninomiya, Mitsutaka Nakashima, et al.
Internal Medicine (Tokyo, Japan)|November 16, 2020
Successful Treatment with Benralizumab for Allergic Bronchopulmonary Aspergillosis That Developed after Disastrous Heavy Rainfall in Western JapanHiroaki Matsuura, Keiichi Fujiwara, Hiroki Omori, et al.
Case Reports in Oncology|January 27, 2022
Thrombotic Microangiopathy Associated with Gemcitabine in Non-Small Cell Lung Cancer: A Case ReportTadahiro Kuribayashi, Keiichi Fujiwara, Kiriko Onishi, et al.
Case Reports in Oncology|July 12, 2021
Optic Perineuritis Associated with Nivolumab Treatment for Non-Small Cell Lung CancerKenji Takada, Keiichi Fujiwara, Eri Ando, et al.
Scientific Reports|January 20, 2025
Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancerTadahiro Kuribayashi, Rie Kinoshita, Kiichiro Ninomiya, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2026
ULK1, a novel therapeutic target to delay drug tolerance to EGFR-TKIs in an EGFR-mutant non-small cell lung cancer modelAyako Morita, Kammei Rai, Tadahiro Kuribayashi, et al.
Molecular Cancer Therapeutics|May 29, 2025
Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR MutationSachi Okawa, Shuta Tomida, Tadahiro Kuribayashi, et al.
Cancer Research Communications|January 13, 2026
Clinical characteristics and spatial transcriptome analysis of non-small cell lung cancers exhibiting early alectinib resistance: a retrospective OLCSG studyTadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi, et al.
Thoracic Cancer|May 3, 2024
Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR-mutated lung cancer and pulmonary tuberculosis: A case reportHiroaki Matsuura, Hisao Higo, Tadahiro Kuribayashi, et al.
Pageof 2